Markets:

Overview

News

Currencies

International

Treasuries

Verastem, Inc. - Common Stock (NQ:VSTM)

4.260 UNCHANGED

Streaming Delayed Price Updated: 10:12 AM EDT, May 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Verastem, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Verastem Oncology to Participate in Upcoming Investor Conferences

October 31, 2024

From Verastem Oncology

Via Business Wire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 17, 2024

Via Benzinga

Verastem Oncology Presents Positive Updated RAMP 201 Data for Avutometinib and Defactinib Combination in Recurrent Low-Grade Serous Ovarian Cancer at the International Gynecologic Cancer Society (IGCS) 2024 Annual Meeting

October 17, 2024

From Verastem Oncology

Via Business Wire

Verastem Oncology Announces Details for the Oral Presentation of the Mature RAMP 201 Data Evaluating Avutometinib Plus Defactinib in Recurrent Low-Grade Serous Ovarian Cancer at the IGCS 2024 Annual Meeting

October 09, 2024

From Verastem Oncology

Via Business Wire

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 07, 2024

From Verastem Oncology

Via Business Wire

Verastem Oncology to Present at the 2024 Cantor Global Healthcare Conference

September 10, 2024

From Verastem Oncology

Via Business Wire

Verastem Oncology to Present Mature RAMP 201 Data in Low-Grade Serous Ovarian Cancer at the International Gynecologic Cancer Society 2024 Annual Meeting

September 10, 2024

From Verastem Oncology

Via Business Wire

Verastem Oncology and STAAR Ovarian Cancer Foundation Establish the Inaugural Low-Grade Serous Ovarian Cancer (LGSOC) Awareness Day on September 9, 2024

September 03, 2024

From Verastem Oncology

Via Business Wire

VSTM Stock Earnings: Verastem Beats EPS, Beats Revenue for Q2 2024 ↗

August 09, 2024

VSTM stock results show that Verastem beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

Verastem Oncology Reports Second Quarter 2024 Financial Results and Highlights Recent Business Updates

August 08, 2024

From Verastem Oncology

Via Business Wire

Verastem Oncology Receives FDA Orphan Drug Designation for Avutometinib and Defactinib for the Treatment of Pancreatic Cancer

July 29, 2024

From Verastem Oncology

Via Business Wire

Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 24, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

July 24, 2024

It's time to dive into the biggest pre-market stock movers for Wednesday as we check out all of the hottest news to start the day with!

Via InvestorPlace

Why Enphase Energy Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗

July 24, 2024

Via Benzinga

Verastem Oncology Announces Pricing of $55.0 Million Public Offering of Common Stock, Warrants and Pre-Funded Warrants

July 23, 2024

From Verastem Oncology

Via Business Wire

Bragar Eagel & Squire, P.C. Is Investigating Verastem, Helios, and LegalZoom and Encourages Investors to Contact the Firm

July 23, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Verastem Oncology Announces Proposed Public Offering of Common Stock, Warrants and Pre-Funded Warrants

July 23, 2024

From Verastem Oncology

Via Business Wire

Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

July 12, 2024

Via Benzinga

Verastem Oncology Announces First Patient Dosed with GFH375/VS-7375, a KRAS G12D (ON/OFF) Inhibitor, in a Phase 1/2 Trial in China as Part of Collaboration with GenFleet Therapeutics

July 12, 2024

From Verastem Oncology

Via Business Wire

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 08, 2024

From Verastem Oncology

Via Business Wire

Verastem Oncology Announces Addition to Russell 3000® and Russell Microcap® Indexes

July 01, 2024

From Verastem Oncology

Via Business Wire

VERASTEM ALERT: Bragar Eagel & Squire, P.C. is Investigating Verastem, Inc. on Behalf of Verastem Stockholders and Encourages Investors to Contact the Firm

June 10, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Verastem, Inc. (VSTM)

June 07, 2024

From Kirby McInerney LLP

Via Business Wire

7 F-Rated Stocks to Avoid at All Costs in June ↗

June 06, 2024

The stock market is doing well this year, so it would be a tragedy to own F-rated stocks. Here are some key stocks to avoid in June.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Intraday Session ↗

May 27, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

May 27, 2024

Via Benzinga

Crude Oil Rises 1%; Verastem Shares Slide ↗

May 24, 2024

Via Benzinga

Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

May 24, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 24, 2024

Via Benzinga

Nasdaq Gains 1%; Intuit Shares Plunge ↗

May 24, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.